This is a Validated Antibody Database (VAD) review about rat Fut4, based on 6 published articles (read how Labome selects the articles), using Fut4 antibody in all methods. It is aimed to help Labome visitors find the most suited Fut4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Fut4 synonym: Fuct
Santa Cruz Biotechnology
mouse monoclonal (C3D-1) |
| Santa Cruz Biotechnology Fut4 antibody (Santa Cruz, sc19648) was used in immunocytochemistry on mouse samples (fig 1a). Int J Mol Sci (2021) ncbi |
mouse monoclonal (C3D-1) |
| Santa Cruz Biotechnology Fut4 antibody (Santa Cruz, sc-19648) was used in immunohistochemistry - free floating section on mouse samples at 1:100 (fig 8a). Front Oncol (2021) ncbi |
mouse monoclonal (C3D-1) |
| Santa Cruz Biotechnology Fut4 antibody (Santa Cruz Biotechnology, sc-19648) was used in immunohistochemistry on mouse samples at 1:300 (fig 7c). Front Oncol (2020) ncbi |
mouse monoclonal (C3D-1) |
| Santa Cruz Biotechnology Fut4 antibody (Santa Cruz, sc-19648) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncol Lett (2016) ncbi |
mouse monoclonal (C3D-1) |
| Santa Cruz Biotechnology Fut4 antibody (Santa Cruz, sc-19648) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig s1). PLoS ONE (2013) ncbi |
Novus Biologicals
mouse monoclonal (MC-480) |
| Novus Biologicals Fut4 antibody (NOVUS, NB100-1831) was used in western blot on human samples (fig 6c). Cell Death Dis (2021) ncbi |
Articles Reviewed
- Ceccarelli M, D Andrea G, Micheli L, Gentile G, Cavallaro S, Merlino G, et al. Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/-/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611. Front Oncol. 2021;11:692053 pubmed publisher
- Wang L, Xu D, Qiao Z, Shen L, Dai H, Ji Y. Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncol Lett. 2016;12:2062-2064 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments